{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-21-000092","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2021-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.786290+00:00","generated_at":"2026-06-28T06:31:24.986325+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BioRestorative reduces authorized shares to 75M after 1-for-4,000 reverse split","bullets":["Board approved reduction of authorized common shares from 300B to 75M, consistent with the 1-for-4,000 reverse split ratio.","Certificate of Amendment filed with Delaware Secretary of State on November 16, 2021; effective immediately.","Reverse split was previously effected on October 27, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-21-000092","json":"https://secwatch.observer/filing/0001021771-21-000092.json","markdown":"https://secwatch.observer/filing/0001021771-21-000092.md","text":"https://secwatch.observer/filing/0001021771-21-000092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177121000092/0001021771-21-000092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177121000092/form8kdtd111621.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:31:24.986325+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}